Helicobacter pylori in Gastric Mucosa-Associated Lymphoid Tissue Type Lymphoma

  • M. Eck
  • B. Schmaußer
  • A. Greiner
  • H. K. Müller-Hermelink
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 156)


Infection with Helicobacter pylori triggers the acquisition of gastric mucosaassociated lymphoid tissue (MALT) and provides the background for MALT-type lymphoma development. This concept has been supported by a high association of H. pylori infection and MALT-type lymphoma and by the regression of most lymphomas after eradication therapy. In almost all patients with MALT-type lymphoma, serum antibodies to H. pylori were detectable. However, H. pylori was found only in 78% of the patients on histological examination. In addition to other effects, changes in the gastric micromilieu caused by tumor infiltration of the gastric mucosa may be responsible for the loss of the bacterium. The discrepancy of high seroprevalence and lower histological yield has been already described in other gastric diseases, e.g. atrophic gastritis or gastric carcinoma with extensive destruction of the gastric mucosa. H. pylori strains expressing the CagA protein have been associated with duodenal ulceration and gastric carcinoma. A very high percentage of patients with MALT-type lymphoma is also infected by CagA+ strains of H. pylori as tested by immunoblotting. Antibodies directed to CagA were detectable in the serum as well as in microcultured gastric mucosa. Infection with H. pylori may be a precondition for the development of gastric MALT-type lymphoma. In particular, CagA+ strains of H. pylori may, together with additional up to now unknown factors, play a role in the development of gastric MALT-type lymphoma.


Pylorus Infection Atrophic Gastritis Pylorus Strain Gastric Lymphoma CagA Protein 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Marshall BJ (1983) Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1:1273–1275Google Scholar
  2. 2.
    Marshall BJ, Warren JR (1984) Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulcération. Lancet i:1311–1314CrossRefGoogle Scholar
  3. 3.
    Rauws EAJ, Langenberg W, Houthoff HJ, Zanen HC, Tytgat GNJ (1988) Campylobacter pyloridis-associated chronic active antral gastritis. Gastroenterology 94:33–40PubMedGoogle Scholar
  4. 4.
    Dixon MF (1991) Helicobacter pylori and peptic ulceration: histopathological aspects. J Gastroenterol Hepatol 6:125–130PubMedCrossRefGoogle Scholar
  5. 5.
    Foreman D, Eurogast Study Group (1993) An international association between Helicobacter pylori infection and gastric cancer. Lancet 341:359–362Google Scholar
  6. 6.
    Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK (1991) Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325:1127–1131PubMedCrossRefGoogle Scholar
  7. 7.
    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (1994) Helicobacter pylori. In: Schistosomes, liver flukes, and Helicobacter pylori: views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. IARC, Lyon, pp 177–240Google Scholar
  8. 8.
    Wyatt JI, Rathbone BJ (1988) Immune response of the gastric mucosa to Campylobacter pylori. Scand J Gastroenterol 23(142):44–49CrossRefGoogle Scholar
  9. 9.
    Stolte M, Eidt S (1989) Lymphoid follicles in the antral mucosa: immune response to Campylobacter pylori. J Clin Pathol 42:1269–1271PubMedCrossRefGoogle Scholar
  10. 10.
    Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG (1991) Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 338:1175–1176PubMedCrossRefGoogle Scholar
  11. 11.
    Eidt S, Stolte M, Fischer R (1994) Helicobacter pylori gastritis and primary gastric non Hodgkin’s lymphomas. J Clin Pathol 47:436–439PubMedCrossRefGoogle Scholar
  12. 12.
    Parsonett J, Hansen S, Rodriguez L, Gelb A, Warnke R, Jellum E, Orentreich N, Vogelman J, Friedman GD (1994) Helicobacter pylori infection and gastric lymphoma. N Engl J Med 330:1267–1271CrossRefGoogle Scholar
  13. 13.
    Eck M, Schmaußer B, Haas R, Greiner A, Czub S, Müller-Hermelink HK (1997) MALT-type lymphoma of the stomach is associated with Helicobacter pylori strains expressing the CagA protein. Gastroenterology 112(5):1482–1486PubMedCrossRefGoogle Scholar
  14. 14.
    Hussell T, Isaacson PG, Crabtree JE, Spencer J (1993) The response of cells from low grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet 342:571–574PubMedCrossRefGoogle Scholar
  15. 15.
    Hussell T, Isaacson PG, Crabtree JE, Spencer J (1996) Helicobacter pylori-specific tumour-infiltrating T cells provide contact dependent help for the growth of malignant B cells in low-grade gastric lymphoma of mucosa-associated lymphoid tissue. J Pathol 178:122–127PubMedCrossRefGoogle Scholar
  16. 16.
    Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de Boni M, Isaacson PG (1993) Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 342:575–577PubMedCrossRefGoogle Scholar
  17. 17.
    Bayerdörffer E, Neubauer A, Rudolph B, Thiede C, Lehn N, Eidt S, Stolte M (1995) Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. Lancet 345:1591–1594PubMedCrossRefGoogle Scholar
  18. 18.
    Nakamura S, Yao T, Aoyagi K, Iida M, Fujishima M, Tsuneyoshi M (1997) Helicobacter pylori and primary gastric lymphoma: a histopathologic and immunhistochemical analysis of 237 patients. Cancer 79:3–11PubMedCrossRefGoogle Scholar
  19. 19.
    Karnes WE, Samloff IM, Siurala M, Kekki M, Sipponen P, Kim SW, Walsh JH (1991) Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology 101(l):167–174PubMedGoogle Scholar
  20. 20.
    Parsonnet J, Vandersteen D, Goates J, Sibley RK, Pritikin J, Chang Y (1991) Helicobacter pylori infection in intestinal-and diffuse-type gastric adenocarcinomas. J Natl Cancer Inst 83(9):640–643CrossRefGoogle Scholar
  21. 21.
    Wee A, Kang JY, Teh M (1992) Helicobacter pylori and gastric cancer: correlation with gastritis, intestinal metaplasia, and tumor histology. Gut 33(8):1029–1032PubMedCrossRefGoogle Scholar
  22. 22.
    Crabtree JE, Wyatt JI, Sobola GM, Miller G, Tompkins DS, Primrose JN, Morgan AG (1993) Systemic and mucosal humoral immune response to Helicobacter pylori in gastric cancer. Gut 34:1339–1343PubMedCrossRefGoogle Scholar
  23. 23.
    Chan WY, Hui PK, Leung KM, Chow J, Kwok F, Ng SC (1994) Coccoid forms of Helicobacter pylori in the human stomach. Am J Clin Pathol 102:503–507PubMedGoogle Scholar
  24. 24.
    Cutler AF, Prasad VM (1996) Long-term follow-up of Helicobacter pylori serology after successful eradication. Am J Gastroenterol 91(l):85–88PubMedGoogle Scholar
  25. 25.
    Taylor D, Blaser MJ (1991) The epidemiology of Helicobacter pylori infection. Epidemiol Rev 13:42–59PubMedGoogle Scholar
  26. 26.
    Xiang Z, Censini S, Bayelli PF, Telford JL, Figura N, Rappuoli R, Covacci C (1995) Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major type and that CagA is not necessary for expression of the vacuolating cytotoxin. Infect Immun 63:94–98PubMedGoogle Scholar
  27. 27.
    Crabtree JE, Taylor JD, Wyatt JI, Heatley RV, Shallcross TM, Tompkins DS Rathbone BJ (1991) Mucosal recognition of Helicobacter pylori 120 kda protein, peptic ulceration, and gastric pathology. Lancet 338:332–335PubMedCrossRefGoogle Scholar
  28. 28.
    Xiang Z, Bugnoli M, Rappuoli R, Covacci A, Ponzetto A, Crabtree JE (1993) Helicobacter pylori: host response in peptic ulcération. Lancet 341:900–901PubMedCrossRefGoogle Scholar
  29. 29.
    Cover TL, Glupczynski Y, Lage AP, Burette A, Tummuru MKR, Perez-Perez Gl, Blaser MJ (1995) Serologic detection of infection with CagA+ Helicobacter pylori strains. J Clin Microbiol 33:496–1500Google Scholar
  30. 30.
    Cover TL, Dooley CP, Blaser MJ (1990) Characterisation of and human sérologie response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing activity. Infect Immun 58:603–610PubMedGoogle Scholar
  31. 31.
    Covacci A, Censini S, Bugnoli M, Petracca R, Burroni D, Macchia G, Massone A, Papini E, Xiang Z, Figura N, Rappuoli R (1993) Molecular characterisation of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA 90:5791–5795PubMedCrossRefGoogle Scholar
  32. 32.
    Xiang Z, Bugnoli M, Ponzetto A, Morgando A, Figura N, Covacci A, Petracca R, Pennatini C, Censini S, Armellini D, Rappuoli R (1993) Detection in an enzyme immunoassay of an immune response to a recombinant fragment of the 128 kDa protein (CagA) of Helicobacter pylori. Eur J Clin Microbiol Infect Dis 12:739–745PubMedCrossRefGoogle Scholar
  33. 33.
    Peek RM, Miller GG, Tham KT, Perez-Perez GL, Zhao X, Atherton JC, Blaser MJ (1995) Heightened inflammatory response and cytokine expression in vivo to CagA+ Helicobacter pylori strains. Lab Invest 71:760–770Google Scholar
  34. 34.
    Kuipers EJ, Perez-Perez GI, Meuwissen SG, Blaser MJ (1995) Helicobacter pylori and atrophie gastritis: importance of the cagA status. J Natl Cancer Inst 87:1777–1780PubMedCrossRefGoogle Scholar
  35. 35.
    Blaser ML, Perez-Perez GL, Kleanthous H, Cover TL, Peek RM, Chyou PH, Stemmermann GN, Nomura A (1995) Infection with Helicobacter pylori strains possessing CagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 55:2111–2115PubMedGoogle Scholar
  36. 36.
    Parsonnet J, Friedman GD, Orentreich N, Vogelman H (1997) Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 40:297–301PubMedGoogle Scholar
  37. 37.
    Blaser MJ (1997) Heterogeneity of Helicobacter pylori. Eur J Gastroenterol Hepatol 9:3–6CrossRefGoogle Scholar
  38. 38.
    Yamaoka Y, Kita M, Kodama T, Sawai N, Tanahashi T, Kashima K, Imanishi J (1998) Chemokines in the gastric mucosa in Helicobacter pylori infection. Gut 42:609–617PubMedCrossRefGoogle Scholar
  39. 39.
    D’Elios MM, Manghetti M, De Carli M, Costa F, Baldari CT, Burroni D, Telford JL, Romagnani S, Del Prete G (1997) T Helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. J Immunol 158:962–967PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2000

Authors and Affiliations

  • M. Eck
    • 1
  • B. Schmaußer
    • 1
  • A. Greiner
    • 1
  • H. K. Müller-Hermelink
    • 1
  1. 1.Institut für PathologieUniversität WürzburgWürzburgGermany

Personalised recommendations